Skip to main content
Top
Published in: Familial Cancer 3/2013

01-09-2013 | Short Communication

A complex endocrine conundrum

Authors: G. Bano, V. Siedel, N. Beharry, P. Wilson, T. Cranston, S. Hodgson

Published in: Familial Cancer | Issue 3/2013

Login to get access

Abstract

We describe a case of recurrent primary hyperparathyroidism, manifested as 3 metachronous parathyroid adenomata, in a 50 year-old woman who also had Hashimoto hypothyroidism, gastric gastrointestinal stromal tumour (GIST), cysts in liver and kidneys, 5 intestinal polyps (one of these a villous adenoma), diverticulitis and telangiectasia of lips. She did not have medullary thyroid carcinoma (MTC). Genetic analysis of the CDC73 gene [for Hyperparathyroidism—jaw tumor (HPT-JT)], MEN1 for Multiple Endocrine Neoplasia Type1, CDKN1B for MEN4, SDHB and SDHD for Paraganglioma/Pheochromocytoma susceptibility, VHL for von Hippel-Lindau Syndrome, BMPR1A and SMAD4 for Juvenile Polyposis Syndrome (JPS) (sequencing and MLPA), karyotype and array CGH (44 K) were all normal. She was found to be homozygous for a synonomous germline variant in exon 14 (p. Ser836Ser) of the RET oncogene. This RET variant is of unclear clinical significance, and has been previously reported both in normal individuals and in individuals with MTC. It is unlikely that homozygosity for the RET variant has been casual in the multiple pathologies that our patient has developed.
Literature
1.
go back to reference Ruiz A, Antiñolo G, Fernández RM, Eng C, Marcos I, Borrego S (2001) Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population. Clin Endocrinol 55:399–402CrossRef Ruiz A, Antiñolo G, Fernández RM, Eng C, Marcos I, Borrego S (2001) Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population. Clin Endocrinol 55:399–402CrossRef
2.
go back to reference Machens A, Spitschak A, Lorenz K, Pützer BM, Dralle H (2011) Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation? Clin Endocrinol 75:801–805CrossRef Machens A, Spitschak A, Lorenz K, Pützer BM, Dralle H (2011) Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation? Clin Endocrinol 75:801–805CrossRef
3.
go back to reference Machens A, Frank-Raue K, Lorenz K, Rondot S, Raue F, Dralle H (2012) Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer. Clin Endocrinol 76:691–697CrossRef Machens A, Frank-Raue K, Lorenz K, Rondot S, Raue F, Dralle H (2012) Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer. Clin Endocrinol 76:691–697CrossRef
4.
go back to reference Baumgartner-Parzer SM, Lang R, Wagner L, Heinze G, Niederle B, Kaserer K, Waldhäusl W, Vierhapper H (2005) Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma? J Clin Endocrinol Metabol 90:6232–6236CrossRef Baumgartner-Parzer SM, Lang R, Wagner L, Heinze G, Niederle B, Kaserer K, Waldhäusl W, Vierhapper H (2005) Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma? J Clin Endocrinol Metabol 90:6232–6236CrossRef
5.
go back to reference Costa P, Domingues R, Sobrinho LG, Bugalho MJ (2005) RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population. Endocrine 27:239–243PubMedCrossRef Costa P, Domingues R, Sobrinho LG, Bugalho MJ (2005) RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population. Endocrine 27:239–243PubMedCrossRef
6.
go back to reference Siqueira DR, Romitti M, da Rocha AP, Ceolin L, Meotti C, Estivalet A, Puñales MK, Maia AL (2010) The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma. Endocr Relat Cancer 17:953–963PubMedCrossRef Siqueira DR, Romitti M, da Rocha AP, Ceolin L, Meotti C, Estivalet A, Puñales MK, Maia AL (2010) The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma. Endocr Relat Cancer 17:953–963PubMedCrossRef
7.
go back to reference Pai R, Arun Nehru G, Samuel P, Paul MJ, Thomas N, Premkumar JA, Hephzibah J, Shanthyl N, Oommen R, Nair A, Seshadri MS, Rajaratnam S (2011) Mutational analysis of RET proto-oncogene among patients with medullary thyroid carcinoma and ‘at risk’ carriers from India. Clinical Endocrinol 75:571–572CrossRef Pai R, Arun Nehru G, Samuel P, Paul MJ, Thomas N, Premkumar JA, Hephzibah J, Shanthyl N, Oommen R, Nair A, Seshadri MS, Rajaratnam S (2011) Mutational analysis of RET proto-oncogene among patients with medullary thyroid carcinoma and ‘at risk’ carriers from India. Clinical Endocrinol 75:571–572CrossRef
Metadata
Title
A complex endocrine conundrum
Authors
G. Bano
V. Siedel
N. Beharry
P. Wilson
T. Cranston
S. Hodgson
Publication date
01-09-2013
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2013
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-012-9594-7

Other articles of this Issue 3/2013

Familial Cancer 3/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine